Who founded NIRAMAI* Cancer Screening?

NIRAMAI* Cancer Screening was founded by Geetha Manjunath in 2016.

Who are NIRAMAI* Cancer Screening's investors?

NIRAMAI* Cancer Screening's investors include 500 Global, Ankur Capital, Axilor Ventures, pi Ventures.

NIRAMAI* Cancer Screening

Founded 2016 · 68 employees on LinkedIn · 4 known investors

Find your way into NIRAMAI* Cancer Screening

346 people in our graph share verified history with the NIRAMAI* Cancer Screening team — schools, employers, funds. One of them is your warm intro.

Ana Andreescuunlockedknows Geetha Manjunath · together at Hewlett-Packard Laboratories (overlapped)

×11knows the team · via Hewlett-Packard Laboratories

Niramai develops an AI-based, radiation-free thermal imaging medical device (Thermalytix, SMILE-100, and Mythri) for early detection of breast cancer, offering a low-cost, portable, non-invasive screening tool for use in clinics, hospitals, and outreach camps. The technology serves healthcare providers screening women across a wide age range and is deployed in over 22 countries.

AI & Machine Learning Digital Health Healthtech Medical Devices

Founders & leadership

NIRAMAI* Cancer Screening was founded in 2016 by Geetha Manjunath.

Geetha Manjunath inFounder and Chief Executive OfficerDr. Geetha Manjunath holds a PhD in Computer Science from the Indian Institute of Science and an MBA from Kellogg School of Management. She spent over 25 years in IT research and development, including roles as a researcher at Xerox Research and Hewlett Packard Labs and as Lab Director for Data Analytics at Xerox, before founding NIRAMAI to develop AI-based thermal imaging for breast cancer screening.

Board

Nidhi Mathur in 𝕏Co-Founder and COO2016–2019Investor at Axilor Ventures

Investors · 4

500 GlobalSan Francisco · $150K

Ankur CapitalMumbai · $275K – $15M

Axilor VenturesBengaluru

pi VenturesreportedIndia · $250K – $3M

Frequently asked questions

What does NIRAMAI* Cancer Screening do?: Niramai develops an AI-based, radiation-free thermal imaging medical device (Thermalytix, SMILE-100, and Mythri) for early detection of breast cancer, offering a low-cost, portable, non-invasive screening tool for use in clinics, hospitals, and outreach camps. The technology serves healthcare providers screening women across a wide age range and is deployed in over 22 countries.
Who founded NIRAMAI* Cancer Screening?: NIRAMAI* Cancer Screening was founded by Geetha Manjunath in 2016.
Who are NIRAMAI* Cancer Screening's investors?: NIRAMAI* Cancer Screening's investors include 500 Global, Ankur Capital, Axilor Ventures, pi Ventures.